High-fat diet-mediated lipotoxicity and insulin resistance is related to impaired lipase expression in mouse skeletal muscle

Endocrinology

Volumn 154, Issue 4, 2013, Pages 1444-1453

  Badin, Pierre Marie ^a,b   Vila, Isabelle K ^a,b   Louche, Katie ^a,b   Mairal, Aline ^a,b   Marques, Marie Adeline ^a,b   Bourlier, Virginie ^a,b   Tavernier, Geneviève ^a,b   Langin, Dominique ^a,b,c   Moro, Cedric ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; INSULIN; INSULIN RECEPTOR; PROTEIN KINASE C EPSILON; PROTEIN KINASE C THETA; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE IDENTIFICATION; GLUCOSE INTOLERANCE; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPOTOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; THYMOMA; WILD TYPE;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ANIMALS; CARRIER PROTEINS; DIET, HIGH-FAT; DIGLYCERIDES; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPASE; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHORYLATION; WEIGHT GAIN;

EID: 84875844957     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2029     Document Type: Article

References (61)

1. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787-835, ix.
2. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7-18.
3. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol. 1999;276:E977-E989.
4. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr. 2002;22:325-346.
5. Moro C, Bajpeyi S, Smith SR. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol. 2008;294:E203-E213.
6. Pickersgill L, Litherland GJ, Greenberg AS, Walker M, Yeaman SJ. Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem. 2007;282:12583-12589.
7. Badin PM, Louche K, Mairal A, et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes. 2011;60:1734-1742.
8. Holland WL, Brozinick JT, Wang LP, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesityinduced insulin resistance. Cell Metab. 2007;5:167-179.
9. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes. 2002;51:2005-2011.
10. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999;103:253-259.
11. Adams JM 2nd, Pratipanawatr T, Berria R, et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes. 2004;53:25-31.
12. Zechner R, Zimmermann R, Eichmann TO, et al. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012;15:279-291.
13. Haemmerle G, Zimmermann R, Hayn M, et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem. 2002;277:4806-4815.
14. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312:734-737.
15. Prats C, Donsmark M, Qvortrup K, et al. Decrease in intramuscular lipid droplets and translocation of HSL in response to muscle contraction and epinephrine. J Lipid Res. 2006;47:2392-2399.
16. Wolins NE, Quaynor BK, Skinner JR, et al. OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization. Diabetes. 2006;55:3418-3428.
17. Toye AA, Lippiat JD, Proks P, et al. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia. 2005;48:675-686.
18. Ayala JE, Samuel VT, Morton GJ, et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech. 2010;3:525-534.
19. Mauvais-Jarvis F, Virkamaki A, Michael MD, et al. A model to explore the interaction between muscle insulin resistance and β-cell dysfunction in the development of type 2 diabetes. Diabetes. 2000; 49:2126-2134.
20. Virkamaki A, Rissanen E, Hamalainen S, Utriainen T, Yki-Jarvinen H. Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake. Diabetes. 1997;46:1106-1110.
21. Kraegen EW, James DE, Jenkins AB, Chisholm DJ. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol. 1985;248:E353-E362.
22. Nishiumi S, Ashida H. Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci Biotechnol Biochem. 2007;71:2343-2346.
23. Bostrom P, Andersson L, Vind B, et al. TheSNAREprotein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance/type 2 diabetes. Diabetes. 2010;59:1870-1878.
24. Moro C, Galgani JE, Luu L, et al. Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab. 2009;94:3440-3447.
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
26. Barrans A, Collet X, Barbaras R, et al. Hepatic lipase induces the formation of pre-β 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem. 1994;269:11572-11577.
27. Hessvik NP, Bakke SS, Fredriksson K, et al. Metabolic switching of human myotubes is improved by n-3 fatty acids. J Lipid Res. 2010; 51:2090-2104.
28. Li Y, Soos TJ, Li X, et al. Protein kinase Cθ inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J Biol Chem. 2004;279: 45304-45307.
29. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-as-sociated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277:50230-50236.
30. Ruiz-Alcaraz AJ, Liu HK, Cuthbertson DJ, et al. A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration. Biochem J. 2005;392:345-352.
31. Deshmukh AS, Hawley JA, Zierath JR. Exercise-induced phosphoproteins in skeletal muscle. Int J Obes (Lond). 2008;4(suppl 32): S18-S23.
32. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;2(suppl 32): S157-S163.
33. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852-871.
34. Chibalin AV, Leng Y, Vieira E, et al. Downregulation of diacylglycerol kinase δ contributes to hyperglycemia-induced insulin resistance. Cell. 2008;132:375-386.
35. Ussher JR, Koves TR, Cadete VJ, et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes. 2010;59:2453-2464.
36. Hage Hassan R, Hainault I, Vilquin JT, et al. Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells. Diabetologia. 2012;55:204-214.
37. Rieusset J, Chauvin MA, Durand A, et al. Reduction of endoplasmic reticulum stress using chemical chaperones or Grp78 overexpression does not protect muscle cells from palmitate-induced insulin resistance. Biochem Biophys Res Commun. 2012;417:439-445.
38. Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes. 2000;49:1353-1358.
39. Jocken JW, Roepstorff C, Goossens GH, et al. Hormone-sensitive lipase serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of β-adrenergic stimulation. Diabetes. 2008;57:1834-1841.
40. Sanchez-Pinera P, Micol V, Corbalan-Garcia S, Gomez-Fernandez JC. A comparative study of the activation of protein kinase Cα by different diacylglycerol isomers. Biochem J. 1999;337(pt 3):387-395.
41. Igal RA, Coleman RA. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem. 1996;271:16644-16651.
42. Badin PM, Loubiere C, Coonen M, et al. Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58. J Lipid Res. 2012;53:839-848.
43. Bezaire V, Mairal A, Ribet C, et al. Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes. J Biol Chem. 2009;284:18282-18291.
44. Anthonsen MW, Ronnstrand L, Wernstedt C, Degerman E, Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem. 1998;273:215-221.
45. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, andAMPK. Am J Physiol Cell Physiol. 2010;298:C961-C971.
46. Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, et al. Peroxisome proliferator-activated receptor γ-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol. 2012;32:1555-1565.
47. Blaak EE, Schiffelers SL, Saris WH, Mensink M, Kooi ME. Impaired β-adrenergically mediated lipolysis in skeletal muscle of obese subjects. Diabetologia. 2004;47:1462-1468.
48. Mulder H, Sorhede-Winzell M, Contreras JA, et al. Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem. 2003;278:36380-36388.
49. Park SY, Kim HJ, Wang S, et al. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am J Physiol. 2005;289:E30-E39.
50. Harada K, Shen WJ, Patel S, et al. Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSLdeficient mice. Am J Physiol. 2003;285:E1182-E1195.
51. Brasaemle DL, Rubin B, Harten IA, Gruia-Gray J, Kimmel AR, Londos C. PerilipinAincreases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem. 2000;275: 38486-38493.
52. Subramanian V, Rothenberg A, Gomez C, et al. PerilipinAmediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem. 2004;279:42062-42071.
53. Bosma M, Minnaard R, Sparks LM, et al. The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria. Histochem Cell Biol. 2012;137:205-216.
54. Wang H, Bell M, Sreenevasan U, et al. Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem. 2011;286:15707-15715.
55. Wang H, Sreenevasan U, Hu H, et al. Perilipin 5, a lipid dropletassociated protein, provides physical and metabolic linkage to mitochondria. J Lipid Res. 2011;52:2159-2168.
56. Granneman JG, Moore HP, Mottillo EP, Zhu Z, Zhou L. Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase. J Biol Chem. 2011;286:5126-5135.
57. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol. 1992;6:1634-1641.
58. Garcia-Roves P, Huss JM, Han DH, et al. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci USA. 2007;104:10709-10713.
59. Dalen KT, Dahl T, Holter E, et al. LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues. Biochim Biophys Acta. 2007;1771:210-227.
60. Frangioudakis G, Garrard J, Raddatz K, Nadler JL, Mitchell TW, Schmitz-Peiffer C. Saturated-and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. Endocrinology. 2010;151:4187-4196.
61. Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH. Upregulation of myocellularDGAT1augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest. 2007;117:1679-1689.